Dr Eberhard Zinn, Ferring Board Member, dies at 66
Lausanne, Switzerland – March 15, 2004 –
Ferring founding board member, Dr. Eberhard Zinn died last week; he was 66 years old.
Dr Zinn has been a member of the Board of Ferring Holding SA, the holding company for the group since its establishment in 2000.
Dr Zinn had a strong academic background having studied economics at the Universities of Hamburg, Turin and Innsbruck before going onto earn a doctorate from the University of Innsbruck and an MBA from the French business school INSEAD. His career with the Chase Manhattan Bank took him to New York, Paris and Frankfurt, and he later worked for Deutsche Girozentrale – Deutsche Kommunalbank in Frankfurt. Most recently he was a member of the Supervisory Board of Bayerische Landesbank in Munich.
“During his tenure as board member, Dr Zinn worked with us to construct the corporate and financial framework necessary to support the Group’s planned future growth”, said Frederik Paulsen, Ferring’s Executive Chairman. “His wide experience particularly in relation to project funding and currency movements will be greatly missed”.
Ferring offers its sincere condolences to Dr. Zinn’s wife and family.
About Ferring Pharmaceuticals
Ferring is a Swiss research driven, specialty biopharmaceutical company active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynecology, infertility and urology.
In recent years Ferring has expanded beyond its traditional European base and now has operating subsidiaries in over 40 countries.
To learn more about Ferring or our products please visit us at: